About Medios AG
Medios AG is a company based in Berlin (Germany) founded in 2016. It operates as a B2B. Medios AG has completed 3 acquisitions, including Ceban, Ceban Pharmaceuticals and Medios. Medios AG offers products and services including Specialty Pharma Services and Advanced Therapies. Medios AG operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
- Headquarter Berlin, Germany
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Medios Ag
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Ceban
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Medios AG
Medios AG is a publicly listed company on the XETR with ticker symbol ILM1 in Germany, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Medios AG
Medios AG offers a comprehensive portfolio of products and services, including Specialty Pharma Services and Advanced Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides innovative drug therapies for pharmacies and doctors
Offers biotechnological precision medicine solutions
Funding Insights of Medios AG
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Medios AG
Medios AG has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Ceban, Ceban Pharmaceuticals and Medios. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Compounding pharmacy services are offered independently in Breda.
|
2004 | ||||
|
Pharmaceutical products are distributed by Ceban Pharmaceuticals.
|
1980 | ||||
|
Diversified drugs are distributed by Blisterzentrum Baden in Germany.
|
0 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Medios AG
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Medios Ag Comparisons
Competitors of Medios AG
Medios AG operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Medios Ag
Frequently Asked Questions about Medios AG
When was Medios AG founded?
Medios AG was founded in 2016.
Where is Medios AG located?
Medios AG is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
What does Medios AG do?
Medios AG, based in Berlin, Germany, is a market leader in Specialty Pharma, ensuring innovative drug therapies reach people across Europe. They offer services from drug supply to patient-specific treatments for pharmacies, doctors, pharmaceutical companies, and clinical study operators. Additionally, they focus on advanced biotechnological precision medicine, emphasizing sustainability and corporate values while serving healthcare professionals and investors.
Who are the top competitors of Medios AG?
Medios AG's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
What products or services does Medios AG offer?
Medios AG offers Specialty Pharma Services and Advanced Therapies.
Is Medios AG publicly traded?
Yes, Medios AG is publicly traded on XETR under the ticker symbol ILM1.
How many acquisitions has Medios AG made?
Medios AG has made 3 acquisitions, including Ceban, Ceban Pharmaceuticals, and Medios.
What is Medios AG's ticker symbol?
The ticker symbol of Medios AG is ILM1 on XETR.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.